Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.

TidsskriftUgeskrift for Laeger
Udgave nummer22
Sider (fra-til)2-6
Antal sider5
StatusUdgivet - 14 aug. 2017

ID: 184209021